Haleon and the University of Sydney drive new osteoarthritis research

ROBERT HEYWARD

Haleon, a leading consumer healthcare company, is sponsoring a fve-year fellowship at the University of Sydney focused on exploring the therapeutic benefts of supplements for managing osteoarthritis symptoms and the use of digital health technologies to enhance mobility.

Osteoarthritis, a major cause of disability, affects over 2 million Australians and 595 million people worldwide, posing a signifcant public health challenge and reducing quality of life for aging populations.

The fellowship will support a postdoctoral researcher under the mentorship of renowned osteoarthritis expert, rheumatologist, and researcher, Professor David Hunter.

Professor Hunter said the research collaboration represents a shared focus and investment in improving osteoarthritis management: “This is a disabling disease that has a huge impact on the people affected.”

“A collaborative effort between researchers and manufacturers will drive innovation and hopefully improve the lives of those impacted by this devastating disease. Use of supplements and natural ingredients in managing osteoarthritis is an exciting area with a lot of potential. I’m not aware of any other long-term, fve-year projects of this nature that has osteoarthritis as its focus,” said Hunter.

Haleon, the company behind popular health products like Panadol, Voltaren, Centrum, and Caltrate, is partnering with the University of

Sydney to pursue better management strategies for osteoarthritis and improve outcomes for those affected.

Dr. Bincy Thampi, Medical & Scientifc Affairs Lead at Haleon ANZ, emphasized that the fellowship aligns with Haleon’s dedication to advancing science and innovation in consumer healthcare.

“As global leaders in pain management and everyday health, Haleon has a strong commitment to scientifc research that drives innovative self-care and improves consumer health outcomes. This partnership illustrates Haleon’s commitment to advancing trusted science for our products to better everyday health and we’re excited to see where this partnership with University of Sydney leads,” said Thampi.